The swine vaccine market is projected to grow from USD 1.9 billion in 2025 to USD 3.3 billion by 2035, at a CAGR of 5.8%. Porcine Circovirus Type 2 will dominate with a 23.5% market share, while inactivated vaccines will lead the product segment with a 27.0% share.